374 related articles for article (PubMed ID: 37843359)
21. Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant?
Duong BV; Larpruenrudee P; Fang T; Hossain SI; Saha SC; Gu Y; Islam MS
Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457468
[TBL] [Abstract][Full Text] [Related]
22. The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection.
Martins M; do Nascimento GM; Nooruzzaman M; Yuan F; Chen C; Caserta LC; Miller AD; Whittaker GR; Fang Y; Diel DG
J Virol; 2022 Sep; 96(17):e0096122. PubMed ID: 36000850
[TBL] [Abstract][Full Text] [Related]
23. Comparison of SARS-Cov-2 omicron variant with the previously identified SARS-Cov-2 variants in Egypt, 2020-2022: insight into SARS-Cov-2 genome evolution and its impact on epidemiology, clinical picture, disease severity, and mortality.
Kandeel A; Moatasim Y; Fahim M; Bahaaeldin H; El-Shesheny R; Roshdy WH; Kamel MN; Shawky S; Gomaa M; Naguib A; Guindy NE; Deghedy O; Kamel R; Khalifa M; Galal R; Hassany M; Mahmoud G; Kandeil A; Afifi S; Mohsen A; Fattah MA; Kayali G; Ali MA; Abdelghaffar K
BMC Infect Dis; 2023 Aug; 23(1):542. PubMed ID: 37596534
[TBL] [Abstract][Full Text] [Related]
24. Omicron: The pandemic propagator and lockdown instigator - what can be learnt from South Africa and such discoveries in future.
Banerjee I; Robinson J; Banerjee I; Sathian B
Nepal J Epidemiol; 2021 Dec; 11(4):1126-1129. PubMed ID: 35070471
[TBL] [Abstract][Full Text] [Related]
25. Editorial: The XBB.1.5 ('Kraken') Subvariant of Omicron SARS-CoV-2 and its Rapid Global Spread.
Parums DV
Med Sci Monit; 2023 Feb; 29():e939580. PubMed ID: 36722047
[TBL] [Abstract][Full Text] [Related]
26. Editorial: World Health Organization (WHO) Variants of Concern Lineages Under Monitoring (VOC-LUM) in Response to the Global Spread of Lineages and Sublineages of Omicron, or B.1.1.529, SARS-CoV-2.
Parums DV
Med Sci Monit; 2022 Jul; 28():e937676. PubMed ID: 35775166
[TBL] [Abstract][Full Text] [Related]
27. Omicron variant evolution on vaccines and monoclonal antibodies.
Sabbatucci M; Vitiello A; Clemente S; Zovi A; Boccellino M; Ferrara F; Cimmino C; Langella R; Ponzo A; Stefanelli P; Rezza G
Inflammopharmacology; 2023 Aug; 31(4):1779-1788. PubMed ID: 37204696
[TBL] [Abstract][Full Text] [Related]
28. Surveillance and Analysis of SARS-CoV-2 Variant Importation - China, January-June 2022.
Feng Y; Zhao X; Yin Z; Wu C; Chen Z; Nie K; A R; Li L; Niu P; Wang J; Wu Y; Wang S; Wang D; Tan W; Wang H; Ma X; Gao GF; Chen C; Xu W
China CDC Wkly; 2022 Dec; 4(50):1136-1142. PubMed ID: 36751558
[TBL] [Abstract][Full Text] [Related]
29. Delineating the Spread and Prevalence of SARS-CoV-2 Omicron Sublineages (BA.1-BA.5) and Deltacron Using Wastewater in the Western Cape, South Africa.
Johnson R; Mangwana N; Sharma JR; Muller CJF; Malemela K; Mashau F; Dias S; Ramharack P; Kinnear C; Glanzmann B; Viraragavan A; Louw J; Surujlal-Naicker S; Nkambule S; Webster C; Mdhluli M; Gray G; Mathee A; Preiser W; Vorster A; Dalvie S; Street R
J Infect Dis; 2022 Oct; 226(8):1418-1427. PubMed ID: 36017801
[TBL] [Abstract][Full Text] [Related]
30. Updated Surveillance Metrics and History of the COVID-19 Pandemic (2020-2023) in Europe: Longitudinal Trend Analysis.
Lundberg AL; Wu SA; Soetikno AG; Hawkins C; Murphy RL; Havey RJ; Ozer EA; Moss CB; Welch SB; Mason M; Liu Y; Post LA
JMIR Public Health Surveill; 2024 Jun; 10():e53551. PubMed ID: 38568186
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of COVID-19 vaccines against SARS-CoV-2 Omicron variants during two outbreaks from March to May 2022 in Quzhou, China.
Yin Z; Fang Q; Wen T; Zheng C; Fu C; Wang S; Li J; Gong X
Hum Vaccin Immunother; 2023 Dec; 19(1):2163813. PubMed ID: 36704960
[TBL] [Abstract][Full Text] [Related]
32. Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants.
Selvavinayagam ST; Yong YK; Joseph N; Hemashree K; Tan HY; Zhang Y; Rajeshkumar M; Kumaresan A; Kalpana R; Kalaivani V; Monika AVD; Suvaithenamudhan S; Kannan M; Murugesan A; Narayanasamy K; Palani S; Larsson M; Shankar EM; Raju S
Front Public Health; 2022; 10():1018399. PubMed ID: 36211690
[TBL] [Abstract][Full Text] [Related]
33. Monitoring algorithm of hospitalized patients in a medical center with SARS-CoV-2 (Omicron variant) infection: clinical epidemiological surveillance and immunological assessment.
Chen CS; Jian MJ; Chang CK; Chung HY; Li SY; Lin JC; Yeh KM; Yang YS; Chen CW; Hsieh SS; Tang SH; Perng CL; Chang FY; Shang HS
PeerJ; 2023; 11():e14666. PubMed ID: 36710871
[TBL] [Abstract][Full Text] [Related]
34. Molecular evolution of SARS-CoV-2 from December 2019 to August 2022.
Wolf JM; Wolf LM; Bello GL; Maccari JG; Nasi LA
J Med Virol; 2023 Jan; 95(1):e28366. PubMed ID: 36458547
[TBL] [Abstract][Full Text] [Related]
35. Transmission Characteristics and Inactivated Vaccine Effectiveness Against Transmission of SARS-CoV-2 Omicron BA.5 Variants in Urumqi, China.
Wang K; Guo Z; Zeng T; Sun S; Lu Y; Wang J; Li S; Luan Z; Li H; Zhang J; Wang Y; Lu Y; Zhao S
JAMA Netw Open; 2023 Mar; 6(3):e235755. PubMed ID: 36995713
[TBL] [Abstract][Full Text] [Related]
36. Differences in clinical characteristics and liver injury between patients diagnosed with the Omicron subvariant BA.5.2 and the prototype of SARS-CoV-2: a single center retrospective study.
Li J; Zhang Q; Xu C; Zhang Y; Lu Y; Ai M; Tan X
BMC Gastroenterol; 2023 Aug; 23(1):271. PubMed ID: 37553605
[TBL] [Abstract][Full Text] [Related]
37. Retrospective analysis of SARS-CoV-2 omicron invasion over delta in French regions in 2021-22: a status-based multi-variant model.
Haschka T; Vergu E; Roche B; Poletto C; Opatowski L
BMC Infect Dis; 2022 Nov; 22(1):815. PubMed ID: 36324075
[TBL] [Abstract][Full Text] [Related]
38. SARS-CoV-2 B.1.1.529 (Omicron) Variant - United States, December 1-8, 2021.
CDC COVID-19 Response Team
MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(50):1731-1734. PubMed ID: 34914670
[TBL] [Abstract][Full Text] [Related]
39. SARS-CoV-2 wastewater monitoring using a novel PCR-based method rapidly captured the Delta-to-Omicron ΒΑ.1 transition patterns in the absence of conventional surveillance evidence.
Chassalevris T; Chaintoutis SC; Koureas M; Petala M; Moutou E; Beta C; Kyritsi M; Hadjichristodoulou C; Kostoglou M; Karapantsios T; Papadopoulos A; Papaioannou N; Dovas CI
Sci Total Environ; 2022 Oct; 844():156932. PubMed ID: 35753493
[TBL] [Abstract][Full Text] [Related]
40. Are twindemics occurring?
Takashita E; Watanabe S; Hasegawa H; Kawaoka Y
Influenza Other Respir Viruses; 2023 Jan; 17(1):e13090. PubMed ID: 36567444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
